View |
|
DR-XY43263
|
Prednisolone
|
Neopred
|
5 mg
|
Tablet
|
Corticosteroid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
19 February 2023
|
26 February 2028
|
View |
|
DR-XY43264
|
Lidocaine Hydrochloride
|
Locaine
|
20 mg/mL (2% w/v)
|
Solution For Injection
|
Local Anesthetic
|
Shreechem Pharmaceuticals Pvt., Ltd
|
India
|
Renewal
|
24 January 2024
|
26 February 2029
|
View |
|
DR-XY43275
|
LOSARTAN POTASSIUM + AMLODIPINE (as besilate)
|
AMLOSAR
|
50mg/5mg
|
Film-Coated Tablet
|
ANGIOTENSIN II RECEPTOR BLOCKER (ARB) and CALCIUM CHANNEL BLOCKER
|
Tunic Healthcare
|
India
|
Renewal
|
02 January 2024
|
04 March 2029
|
View |
|
DR-XY43278
|
Amlodipine (as Besilate)
|
Amlodibloc
|
10mg
|
Tablet
|
Calcium Channel Blocker
|
Jiangsu Pengyao Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
19 March 2024
|
07 March 2029
|
View |
|
DR-XY43279
|
Amlodipine (As Besilate)
|
Amlodibloc
|
5mg
|
Tablet
|
Calcium Channel Blocker
|
Jiangsu Pengyao Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal (E-AR)
|
06 March 2024
|
07 March 2029
|
View |
|
DR-XY43283
|
Atracurium Besilate
|
Atravell
|
10mg/mL(50mg/5mL)
|
Solution For Injection (Iv)
|
Neuromuscular Blocking Agent
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
22 December 2023
|
11 March 2029
|
View |
|
DR-XY43285
|
Atracurium Besilate
|
Atravell
|
10mg/mL(25mg/2.5mL)
|
Solution For Injection (Iv)
|
Neuromuscular Blocking Agent
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
16 November 2023
|
11 March 2029
|
View |
|
DR-XY43286
|
Cefuroxime (as Axetil)
|
Bacxime
|
250 mg
|
Film-Coated Tablet
|
Antibacterial (Second Generation Cephalosporin)
|
Swiss Parenterals Pvt. Ltd.
|
India
|
Renewal
|
25 March 2024
|
05 March 2029
|
View |
|
DR-XY43288
|
Sertaconazole Nitrate
|
Onabet
|
20 mg/g (2% w/w)
|
Cream
|
Antifungal (Imidazole and triazole derivative)
|
Glenmark Pharmaceuticals Ltd.
|
India
|
Automatic Renewal (E-AR)
|
03 January 2024
|
05 March 2029
|
View |
|
DR-XY43293
|
Ascorbic Acid + Rutoside
|
Ascortin
|
500mg/250mg
|
Chewable Tablet
|
Vitamin/Bioflavonoid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
18 November 2023
|
10 March 2029
|
View |
|
DR-XY43294
|
Ascorbic Acid + Rutoside
|
Ascortin
|
500 mg/ 500 mg
|
Chewable Tablet
|
Vitamin/Bioflavonoid
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
29 November 2023
|
10 March 2029
|
View |
|
DR-XY43295
|
Tramadol Hydrochloride
|
Tramklor
|
50mg
|
Tablet
|
Opioid Analgesics
|
Cspc Ouyi Pharmaceutical Co., Ltd.
|
China
|
Automatic Renewal
|
31 July 2023
|
18 November 2028
|
View |
|
DR-XY43297
|
Glycerin
|
Glydem
|
626mg/Ml
|
Rectal Solution (Enema)
|
Laxative / Cathartic
|
Cisen Pharmaceutical Co., Ltd
|
China
|
Renewal
|
06 March 2024
|
20 March 2029
|
View |
|
DR-XY43305
|
Tranexamic Acid
|
Hemanex
|
100 mg/mL (500 mg/5 mL)
|
Solution For Injection (IM/IV)
|
Anti-fibrinolytic
|
Amherst Parenterals, Inc.
|
Philippines
|
Renewal
|
08 December 2023
|
13 March 2029
|
View |
|
DR-XY43308
|
IRBESARTAN
|
IRBEZIL
|
150mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Aurochem Laboratories
|
India
|
Renewal
|
17 April 2024
|
24 March 2029
|
View |
|
DR-XY43311
|
Phenylephrine Hydrochloride
|
Naldec
|
12.5 mg
|
Syrup
|
Nasal Decongestant
|
La Croesus Pharma, Inc.
|
Philippines
|
Renewal
|
24 April 2024
|
17 March 2029
|
View |
|
DR-XY43312
|
Ascorbic Acid + Zinc
|
Ceelin Plus Chewables
|
Formulation: Each chewable tablet contains:
Ascorbic Acid-20mg Ascorbic Acid-80mg (equivalent to 90 mg Sodium Ascorbate) Zinc -5mg (equivalent to 16.03 mg Zinc Citrate Trihydrate)
|
Chewable Tablet
|
Vitamin & Mineral
|
UNILAB Inc.,
|
Philippines
|
Renewal
|
08 May 2024
|
26 May 2029
|
View |
|
DR-XY43313
|
Clopidogrel (as bisulfate)
|
Artheogrel
|
75 mg
|
Film Coated Tablet
|
Antithrombotic
|
Bal Pharma Ltd.
|
India
|
Renewal
|
05 February 2024
|
21 April 2029
|
View |
DR-XY43314_PI_01.pdf
|
DR-XY43314
|
Rilpivirine (as Hydrochloride)
|
Edurant
|
25 mg
|
Film-Coated Tablet
|
Non-nucloeside Reverse Transcriptase Inhibitor
|
Janssen Cilag S.p.A.
|
Italy
|
Automatic Renewal (E-AR)
|
07 February 2024
|
14 March 2029
|
View |
|
DR-XY43317
|
Metformin Hydrochloride
|
Euformin
|
500 mg
|
Film Coated Tablet
|
Oral Hypoglycemic Agent
|
The Acme Laboratories Ltd.
|
Bangladesh
|
Renewal
|
03 December 2023
|
25 March 2029
|